Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Delivra Health Brands Inc V.DHB

Alternate Symbol(s):  DHBUF

Delivra Health Brands Inc. is a Canada-based consumer packaged goods company. The Company provides products that help with pain, sleep, anxiety, and performance through its acquired brands LivRelief and Dream Water. It operates a portfolio of brands under its Consumer Division consisting of Dream Products Inc. and its associated subsidiaries, and Delivra Corp. and its associated subsidiaries. Dream Water produces convenient, travel-friendly, single-serving 2.5oz liquid sleep shots, sleep powder packets that consumers can take with or without water and gummies. Its LivRelief brand offers relief for conditions such as joint and muscle pain, nerve pain, varicose veins, wound healing, and sports performance. It has also added three new products to its portfolio of licensed infused products: Transdermal 1:1 Cream- 250mg CBD:250mg THC; Transdermal CBD Cream with Cooling - 500mg CBD, and Extra Strength Transdermal CBD Cream: 1200mg CBD.


TSXV:DHB - Post by User

Bullboard Posts
Post by uptown59on Feb 28, 2019 9:46pm
138 Views
Post# 29426557

I have read Sedar Documents

I have read Sedar DocumentsFirst, if dividends are important to anyone, buy bank stocks, nothing going on here.

I've read many financials, always trying to find hidden nonsense, for the first time ever, I have full confidence in this ER, HVT has provided full tansparency. I take my hat off to both CEO and CFO. I'm confident posting what I'm about to post, however, if someone can poke holes here, feel free. 

Hopefully my interpretations are correct, if so Shorts have no case here. Share price should rise tomorrow and probably again monday and into tuesday before consolidation. However, anyone engaged here will see that HVT has significant upside.

1. Revenue 3.7M increase of 123% qtr over qtr, 235KGs sold
2. Gross margin of 47%, United Greeneries 53%, so Margins are fantastic
3. Sales Canadian, (pot) 2.079M, US (DW i think), 1.648M, Ireland (Satipharm i think, 13.8K), irish maybe switching from Guiness to Gellpells, haha
4. If i understand correctly, HVT is sitting on 5.4M inventory, Dried flower and Gellpells, we will see how this plays on next quarter, but could be good.
5. Burb is doing what they say, 2 stores in 2019, 6 by 2021. I think this is a bit of liability, but HVT has 19.9% control of destiny, plus quality pot to supply Burb, branding opportunity. Burb has more to gain than HVT has to loose, so not an issue for HVT. I trust Grant to make this work.
6. Cash 41M, burn of aprox 9M in previous 6 months, could be slighly off, (3.5M net loss, 750K severance former CEO( not to alarming), 600K consultant??, ongoing expansion, salarys etc. everything seems to jive.
7. Outsatnding options, does not increase full dilution, 15,225M, @ avg .79, considering total outsatnding shares, this is good for us, share holders.
8. Total warrants for exercise not really significant, i'm not sure but it looks like about 16M, so not significant and have to be exercised between.75 and 2.30, this does not trouble me at all. HVT has a low float by comparable standards, which means share price can move quick.
9. Total assets 105M, liabilities , 3.5M, this is ridiculus, my other picks have liabilities almost equal with assets, this is huge, this alone should drive share price.
10.Going forward, Europe CBD is legal, Med purposes must meet requirements so Best Practices, clinical trials, HVT is there, beautiful thing. CBD in Europe to be 2B+, Satipahrm is there early days. Sleep aids globally 49B, 80B by 2022, 17 million canadians suffer from sleep deprivation, and HVT is sticking to 20,000kg for end of 2019, this is massive

Tomorrow, i wish everyone good luck, I cannot believe Shorts have a case of sell the news here, because going forward, HVT is firing on all 16 cylinders.

GLTAL



Bullboard Posts